---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015653"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:25:00.308207+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma moves principal executive office to Estero, Florida

## Summary
- Board changed principal executive office to 23150 Fashion Drive, Suite 232, Estero, FL 33928 effective June 17, 2025.
- Former address was 194 Candelaro Drive, #233, Humacao, Puerto Rico 00791.
- New office is the company's principal place of business and headquarters.

## SEC filing metadata
- accession: 0001641172-25-015653
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/0001641172-25-015653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015653
- JSON: https://secwatch.observer/filing/0001641172-25-015653.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015653.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.